Page 269 - Read Online

Candela et al. Vessel Plus 2018;2:28 I http://dx.doi.org/10.20517/2574-1209.2018.31 Page 9 of 9

2005;14:e9.
41. Morris RW, Watterson LM, Westhorpe RN, Webb RK. Crisis management during anaesthesia: hypotension. Qual Saf Health Care
2005;14:e11.
42. Abawi M, Nijhoff F, Agostoni P, Emmelot-Vonk MH, de Vries R, Doevendans PA, Stella PR. Incidence, predictive factors, and effect of
delirium after transcatheter aortic valve replacement. JACC Cardiovasc Interv 2016;9:160-8.
43. Oguri A, Yamamoto M, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leguerrier
A, Prat A, Lievre M, Chevreul K, Dubois-Rande JL, Chopard R, Van Belle E, Otsuka T, Teiger E; FRANCE 2 Registry Investigators.
Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: subanalysis of the French
Aortic National CoreValve and Edwards 2 registry. Circ Cardiovasc Interv 2014;7:602-10.
44. Wöhrle J, Gonska B, Rodewald C, Seeger J, Scharnbeck D, Rottbauer W. Transfemoral aortic valve implantation with the new Edwards
Sapien 3 valve for treatment of severeaortic stenosis-impact of valve size in a single center experience. PLoS One 2016;11:e0151247.
45. Kodali S, Thourani VH, White J, Malaisrie SC, Lim S, Greason KL, Williams M, Guerrero M, Eisenhauer AC, Kapadia S, Kereiakes
DJ, Herrmann HC, Babaliaros V, Szeto WY, Hahn RT, Pibarot P, Weissman NJ, Leipsic J, Blanke P, Whisenant BK, Suri RM, Makkar
RR, Ayele GM, Svensson LG, Webb JG, Mack MJ, Smith CR, Leon MB. Early clinical and echocardiographic outcomes after SAPIEN
3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J
2016;37:2252-62.
46. Ehret C, Rossaint R, Foldenauer AC, Stoppe C, Stevanovic A, Dohms K, Hein M, Schälte G. Is local anaesthesia a favourable approach
for transcatheter aortic valve implantation? A systematic review and meta-analysis comparing local and general anaesthesia. BMJ Open
2017;7:e016321.
47. Gauthier C, Astarci P, Baele P, Matta A, Kahn D, Kefer J, Momeni M. Mid-term survival after transcatheter aortic valve implantation:
results with respect to the anesthetic management and to the access route (transfemoral versus transapical). Ann Card Anaesth
2015;18:343-51.
48. Lunardi M, Pesarini G, Zivelonghi C, Piccoli A, Geremia G, Ariotti S, Rossi A, Gambaro A, Gottin L, Faggian G, Vassanelli C, Ribichini
F. Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency. Open Heart 2016;3:e000420.
49. Arai T, Lefèvre T, Hovasse T, Hayashida K, Watanabe Y, O’Connor SA, Benamer H, Garot P, Cormier B, Bouvier E, Morice MC,
Chevalier B. Evaluation of the learning curve for transcatheter aortic valve implantation via the transfemoral approach. Int J Cardiol
2016;203:491-7.
50. Bloomfield GS, Gillam LD, Hahn RT, Kapadia S, Leipsic J, Lerakis S, Tuzcu M, Douglas PS. A practical guide to multimodality
imaging of transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2012;5:441-55.
51. Arora S, Vavalle JP. Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidence. Ann Cardiothorac
Surg 2017;6:493-7.
52. Hamm CW, Arsalan M, Mack MJ. The future of transcatheter aortic valve implantation. Eur Heart J 2016;37:803-10.